Charles River Laboratories International, Inc.

罗森律师事务所宣布一项代表Charles River Laboratories International, Inc. (NYSE: CRL)的投资人对该公司潜在的集体诉讼请求发起调查。该调查缘起于对Charles River可能向投资公众发布了具有重大误导性的商业信息的指控。

如果您购买了Charles River股票,并且您想参加此次集体诉讼的话,请点击“加入此集体行动”键。

如果您购买了 Charles River 证券,您可能有权获得赔偿,而无需支付任何自付费用或通过应急费用安排产生的费用。

Details of investigation:

2023 年 2 月 22 日,Charles River 公司披露其已收到大陪审团的传票,要求提供与美国司法部(「DOJ」)和美国鱼类及野生动物管理局(「USFWS」)联合调查从柬埔寨非法进口非人类灵长类动物用于研究目的有关的文件,该调查已导致对两名柬埔寨官员以及一个柬埔寨非人类灵长类动物供应商提出刑事起诉。该公司表示将自愿暂停从柬埔寨运送灵长类动物,此举可能会影响该公司为研究目的寻找非人类灵长类动物的能力。此外该公司还警告称,调查可能会损害其业务。

受此消息影响,Charles Rivers 股价在 2023 年 2 月 22 日的盘中交易中下跌 15% 之多,令投资人蒙受损失。

Follow us on:
Company Name: Charles River Laboratories International, Inc.
Stock Symbol: CRL
Class Period: N/A
Court: N/A

Why Rosen Law

The Rosen Law Firm has been ranked among the top 4 law firms each year since 2013 for the number of successful securities class actions on behalf of investors. In 2019 alone, our firm recovered $438 million for investors.

Investors should carefully identify and select experienced counsel with a track record of success leading securities class actions. Often other firms issue press releases about class actions yet do not have comparable experience or resources.

Institutional Shareholders Services ranked the Rosen Law Firm # 1 for the number of securities class action recoveries in 2017.

The Rosen Law Firm represents investors throughout the globe. Our mission is to prosecute securities fraud class actions and protect shareholders’ rights.

Scroll to Top